Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bilateral vocal cord paralysis in multifocal motor neuropathy.

BMJ case reports·2026
Same author

Cell type-specific contextualisation of the human phenome: towards the systematic treatment of all rare diseases.

Genome medicine·2026
Same author

The role of systemic microvascular function in the association between large artery stiffness and cognitive function in older adults.

Journal of hypertension·2026
Same author

Using GPT-4 to annotate the severity of all phenotypic abnormalities within the human phenotype ontology.

Frontiers in digital health·2026
Same author

AI-assisted teams outperform AI-led teams but not human-only teams in assessing research reproducibility in quantitative social science.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Classical HLA class II associations with ALS in Kuwait reveal a DR7-DQ2.2 risk haplotype.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jul 17, 2025

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.2K

Artificial intelligence for dementia research methods optimization.

Magda Bucholc1, Charlotte James2, Ahmad Al Khleifat3

  • 1Cognitive Analytics Research Lab, School of Computing, Engineering & Intelligent Systems, Ulster University, Derry, UK.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|August 28, 2023
PubMed
Summary
This summary is machine-generated.

Artificial intelligence and machine learning show promise for dementia research, but methodological challenges hinder progress. Addressing issues like data sharing, interpretability, and diverse datasets is crucial for improving patient outcomes.

Keywords:
artificial intelligenceclassificationclinical utilitydeep learningdementiageneralizabilityinterpretabilitymachine learningmethods optimizationregressionreplicabilitysemi-supervised learningsupervised learningtransferabilityunsupervised learning

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Related Experiment Videos

Last Updated: Jul 17, 2025

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Area of Science:

  • Computational neuroscience
  • Medical informatics
  • Geriatric medicine

Background:

  • Artificial intelligence (AI) and machine learning (ML) are increasingly applied in dementia research.
  • Methodological challenges limit insights from high-dimensional data and clinical translation.
  • Reproducibility and generalizability are key concerns in AI/ML for dementia.

Purpose of the Study:

  • To identify and address methodological challenges in applying AI and ML to dementia research.
  • To enhance the potential of AI and ML for improving dementia diagnosis, prevention, and management.
  • To promote best practices for robust, generalizable, and interpretable AI/ML models in dementia care.

Main Methods:

  • Review and synthesis of current challenges in AI/ML application for dementia.
  • Emphasis on open-source code, data sharing, and interpretable modeling.
  • Advocacy for diverse datasets and adherence to reporting guidelines.

Main Results:

  • Inadequate reporting of ML procedures impedes result reproduction and replication.
  • Models trained on unrepresentative datasets exhibit poor generalizability.
  • Lack of defined metrics and concerns about interpretability hinder clinical adoption.

Conclusions:

  • Overcoming methodological challenges in AI/ML is essential for advancing dementia research and care.
  • Prioritizing code/data sharing, interpretability, and diverse datasets will improve model robustness and reduce bias.
  • Standardized reporting guidelines are needed for clarity and reproducibility in AI-driven dementia studies.